GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » EV-to-EBITDA

Nanjing Vishee Medical Technology Co (SHSE:688580) EV-to-EBITDA : 14.15 (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nanjing Vishee Medical Technology Co's enterprise value is ¥1,998.5 Mil. Nanjing Vishee Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥141.2 Mil. Therefore, Nanjing Vishee Medical Technology Co's EV-to-EBITDA for today is 14.15.

The historical rank and industry rank for Nanjing Vishee Medical Technology Co's EV-to-EBITDA or its related term are showing as below:

SHSE:688580' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.12   Med: 27.13   Max: 79.91
Current: 13.37

During the past 10 years, the highest EV-to-EBITDA of Nanjing Vishee Medical Technology Co was 79.91. The lowest was 10.12. And the median was 27.13.

SHSE:688580's EV-to-EBITDA is ranked better than
57.99% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.145 vs SHSE:688580: 13.37

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Nanjing Vishee Medical Technology Co's stock price is ¥44.18. Nanjing Vishee Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.872. Therefore, Nanjing Vishee Medical Technology Co's PE Ratio for today is 23.60.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nanjing Vishee Medical Technology Co EV-to-EBITDA Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co EV-to-EBITDA Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 31.88 29.11 19.49 18.85

Nanjing Vishee Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.59 26.61 23.46 18.85 15.97

Competitive Comparison of Nanjing Vishee Medical Technology Co's EV-to-EBITDA

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Vishee Medical Technology Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's EV-to-EBITDA falls into.



Nanjing Vishee Medical Technology Co EV-to-EBITDA Calculation

Nanjing Vishee Medical Technology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1998.486/141.187
=14.15

Nanjing Vishee Medical Technology Co's current Enterprise Value is ¥1,998.5 Mil.
Nanjing Vishee Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥141.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Vishee Medical Technology Co  (SHSE:688580) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nanjing Vishee Medical Technology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=44.18/1.872
=23.60

Nanjing Vishee Medical Technology Co's share price for today is ¥44.18.
Nanjing Vishee Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.872.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nanjing Vishee Medical Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines